ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
Duke University at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
Duke University takes part in 5 sessions at ASHI 2026 in Montréal. Its program focuses on desensitizing highly sensitized kidney transplant candidates, including how carfilzomib plus belatacept affects HLA and anti-microbial antibodies and which antibodies respond. It also covers case-based views of antibody-mediated rejection and the path from HLA discovery to precision medicine.
| Organization | ASHI 2026 Attendance |
|---|---|
Duke University Durham, NC | |
Private research university with a school of medicine and the Duke University Health System, which runs organ and stem cell transplant programs. | Talk Wed Oct 28 3:00pm–3:15pm Impact of Carfilzomib (CFZ) + Belatacept (Bela) Desensitization on HLA antibodies in Highly Sensitized Kidney Transplant Candidates HLA antibodies, crossmatching and epletsSolid organ transplantation Talk Thu Oct 29 8:45am–9:30am HLA Discovery to Precision Medicine: The journey is not over HLA typing, sequencing and genotyping Session Thu Oct 29 1:10pm–2:40pm Workshop 4: Beyond the Paradigm: Case-Based Insights into the Spectrum of Antibody-Mediated Rejection in Kidney Transplantation Solid organ transplantationHLA antibodies, crossmatching and eplets Talk Fri Oct 30 11:00am–11:30am Immunogenic Assessment for Desensitization: Which antibodies are amenable to desensitization? HLA antibodies, crossmatching and epletsSolid organ transplantation |
Find decision makers at Duke University
Tell us what you sell and we’ll find the people at Duke University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction